HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roberto Pola Selected Research

Upper Extremity Deep Vein Thrombosis

1/2022Anticoagulant treatment for upper extremity deep vein thrombosis: A systematic review and meta-analysis.
8/2020Upper extremity deep vein thrombosis treated with direct oral anticoagulants: a multi-center real world experience.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roberto Pola Research Topics

Disease

7Ischemia
12/2018 - 07/2003
6Neoplasms (Cancer)
01/2022 - 12/2013
6Inflammation (Inflammations)
02/2013 - 09/2002
6Alzheimer Disease (Alzheimer's Disease)
10/2006 - 09/2002
5Hemorrhage
01/2022 - 12/2002
5Venous Thromboembolism
01/2022 - 08/2012
5COVID-19
10/2021 - 01/2020
5Stroke (Strokes)
06/2020 - 04/2003
3Hereditary Hemorrhagic Telangiectasia
05/2022 - 12/2019
3Ischemic Stroke
08/2012 - 04/2003
3Myocardial Ischemia (Ischemic Heart Diseases)
04/2011 - 06/2003
3Amyloid Plaque
01/2004 - 01/2003
2Upper Extremity Deep Vein Thrombosis
01/2022 - 08/2020
2Thrombosis (Thrombus)
01/2022 - 08/2012
2Pulmonary Embolism
01/2022 - 06/2020
2Respiratory Insufficiency (Respiratory Failure)
01/2021 - 01/2020
2Venous Thrombosis (Deep-Vein Thrombosis)
06/2020 - 01/2020
2Arteriovenous Malformations (Arteriovenous Malformation)
12/2018 - 02/2013
2Intracranial Aneurysm (Cerebral Aneurysm)
01/2014 - 08/2012
2Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2014 - 07/2002
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2014 - 08/2012
2Type 2 Diabetes Mellitus (MODY)
08/2010 - 05/2008
2Dementia (Dementias)
10/2006 - 01/2004
2Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
10/2006 - 07/2002
2Ulcerative Colitis
06/2006 - 04/2005
2Crohn Disease (Crohn's Disease)
06/2006 - 04/2005
2Brain Ischemia (Cerebral Ischemia)
04/2003 - 07/2002
2Neurodegenerative Diseases (Neurodegenerative Disease)
09/2002 - 07/2002
1Breast Neoplasms (Breast Cancer)
01/2022
1Scurvy (Scorbutus)
10/2021
1Epistaxis (Nosebleed)
05/2021
1Rhabdomyolysis
01/2021
1Drug-Related Side Effects and Adverse Reactions
01/2021
1Muscular Diseases (Myopathy)
01/2021
1Myalgia
01/2021
1Retinal Artery Occlusion
06/2020
1Atrial Fibrillation
06/2020
1Myocardial Infarction
06/2020
1Glioma (Gliomas)
01/2020
1Telangiectasis (Telangiectasia)
12/2019
1Inborn Genetic Diseases (Disease, Hereditary)
12/2019
1Cardiovascular Diseases (Cardiovascular Disease)
10/2018
1Fibrosis (Cirrhosis)
03/2014
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
12/2013
1Non-ST Elevated Myocardial Infarction
10/2013
1Necrosis
02/2013
1Disease Susceptibility (Diathesis)
02/2013
1Atherosclerosis
08/2012
1Peripheral Arterial Disease
08/2012
1Vascular Diseases (Vascular Disease)
08/2012
1Abdominal Aortic Aneurysm
08/2012
1Hypertension (High Blood Pressure)
08/2010
1Obesity
08/2010
1Acromegaly
06/2009

Drug/Important Bio-Agent (IBA)

6AnticoagulantsIBA
01/2022 - 09/2016
5Proteins (Proteins, Gene)FDA Link
12/2013 - 07/2003
5Interleukin-6 (Interleukin 6)IBA
02/2013 - 07/2002
4Oxygen (Dioxygen)IBA
01/2020 - 04/2003
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2005 - 11/2003
4CytokinesIBA
11/2004 - 09/2002
4Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
10/2004 - 07/2002
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2013 - 04/2011
2Heparin (Liquaemin)FDA LinkGeneric
01/2020 - 01/2020
2Biological ProductsIBA
12/2018 - 02/2013
2Biomarkers (Surrogate Marker)IBA
05/2017 - 08/2004
2Genetic Markers (Genetic Marker)IBA
01/2014 - 10/2006
1EndoglinIBA
05/2022
1activin AIBA
05/2022
1Enoxaparin (Lovenox)FDA LinkGeneric
01/2022
1edoxabanIBA
01/2022
1Fondaparinux (Arixtra)FDA Link
01/2022
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2022
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
10/2021
1fibrin fragment D (D-dimer)IBA
10/2021
1IronIBA
05/2021
14- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA
01/2021
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2021
1cupric sulfide (CuS)IBA
01/2020
1MicroRNAs (MicroRNA)IBA
10/2018
1matrigelIBA
12/2013
1DystrophinIBA
12/2013
1Troponin T (Troponin T1)IBA
10/2013
1Activins (Activin)IBA
02/2013
1Fibronectins (Fibronectin)IBA
02/2013
1Phosphotransferases (Kinase)IBA
02/2013
1IntegrinsIBA
02/2013
1danaparoid (Orgaran)FDA Link
08/2012
1Lipoprotein(a)IBA
08/2012
1Apoprotein(a) (Apolipoprotein (a))IBA
08/2012
1LipidsIBA
08/2010
1Somatotropin Receptors (Growth Hormone Receptor)IBA
06/2009
1Protein Isoforms (Isoforms)IBA
06/2009

Therapy/Procedure

7Therapeutics
06/2020 - 01/2012
2Central Venous Catheters
01/2022 - 08/2020
1Catheters
01/2022
1Indwelling Catheters (Indwelling Catheter)
01/2022
1Blood Transfusion (Blood Transfusions)
05/2021
1Length of Stay
01/2021
1Secondary Prevention
06/2020
1Noninvasive Ventilation
01/2020